Concepedia

Komal Gupte-Singh

KG

Statistics

Publications

15

Citations

395

H-Index

11

Active since

2015

Affiliations

Bristol-Myers Squibb (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

Dana-Farber Cancer Institute

Cleveland Clinic

Komal Gupte-Singh is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2015–2023

15

Publications

15

Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States

Komal Gupte-Singh, Rakesh R. Singh, Kenneth A. Lawson · Value in Health · 2017 · 89 citations

, , +17

Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition—A Pooled Analysis of Patients With Advanced Melanoma

Meredith M. Regan, Lillian Werner, Sumati Rao et al. · Journal of Clinical Oncology · 2019 · 76 citations · Full text

, , +17

Clinical and Economic Outcomes Associated with Treatment Sequences In Patients With <i>BRAF</i> -Mutant Advanced Melanoma

Ahmad A. Tarhini, David F. McDermott, Apoorva Ambavane et al. · Immunotherapy · 2018 · 35 citations · Full text

, , +17

Comparative Efficacy of Combination Immunotherapy And Targeted Therapy in the Treatment of <i>BRAF</i> -mutant Advanced Melanoma: A Matching-Adjusted Indirect Comparison

Michael B. Atkins, Ahmad A. Tarhini, Michael Rael et al. · Immunotherapy · 2019 · 35 citations · Full text

, , +17

Sequential Treatment Approaches in  the Management of <i>BRAF</i> Wild-Type Advanced Melanoma: A Cost–Effectiveness Analysis

Ahmad A. Tarhini, Ágnes Benedict, David F. McDermott et al. · Immunotherapy · 2018 · 27 citations · Full text

, , +17

1–5 of 15